# Sumitomo Dainippon Pharma Co., Ltd. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/sumitomo-dainippon-pharma-co-ltd/40ead027-5fd5-4deb-a37b-40301cffd612

> Inspection records and compliance data for Sumitomo Dainippon Pharma Co., Ltd. in Suzuka, None. Access full analysis and detailed observations.

---

## Details

- Name: Sumitomo Dainippon Pharma Co., Ltd.
- FEI Number: 3003028650
- City: Suzuka
- State: None
- Country Name: Japan
- Address Line 1: 1450, Yasuzuka-Cho
- Zip Code: None

## Related Documents

- [483 - Sumitomo Dainippon Pharma Co., Ltd. - 2025-08-07](https://www.globalkeysolutions.net/records/483/sumitomo-dainippon-pharma-co-ltd/628e7814-ad3c-4132-bf5c-8987bf6047c2) — source: FDA, date: August 7, 2025
- [483 - Sumitomo Dainippon Pharma Co., Ltd. - 2025-08-07](https://www.globalkeysolutions.net/records/483/sumitomo-dainippon-pharma-co-ltd/2bc62c0d-aa64-4304-8835-9affb19a6448) — source: FDA, date: August 7, 2025
- [483 - Sumitomo Dainippon Pharma Co., Ltd. - 2025-08-07](https://www.globalkeysolutions.net/records/483/sumitomo-dainippon-pharma-co-ltd/86bec48e-adb4-4655-bc52-1a8046463dde) — source: FDA, date: August 7, 2025
- [483 - Sumitomo Dainippon Pharma Co., Ltd. - 2025-08-07](https://www.globalkeysolutions.net/records/483/sumitomo-dainippon-pharma-co-ltd/86a81dce-ec5c-4538-92d1-957b4b070918) — source: FDA, date: August 7, 2025
- [FDA Inspection 1277764 - Sumitomo Dainippon Pharma Co., Ltd. - 2025-08-07](https://www.globalkeysolutions.net/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/43625239-cfee-4173-8772-0af3efdf143c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 7, 2025
- [483 - Sumitomo Dainippon Pharma Co., Ltd. - 2019-11-22](https://www.globalkeysolutions.net/records/483/sumitomo-dainippon-pharma-co-ltd/1731dc44-1562-4b56-a1ab-11523c1ef33a) — source: FDA, date: November 22, 2019
- [FDA Inspection 1113228 - Sumitomo Dainippon Pharma Co., Ltd. - 2019-11-22](https://www.globalkeysolutions.net/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/1c86b0d4-989e-4cae-ad7f-4339b52c4cd9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 22, 2019
- [FDA Inspection 1064584 - Sumitomo Dainippon Pharma Co., Ltd. - 2018-07-27](https://www.globalkeysolutions.net/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/b88eaa22-935f-43cb-9ecc-eb8210e40ed4) — classification: No Action Indicated (NAI), source: FDA, date: July 27, 2018
- [FDA Inspection 990466 - Sumitomo Dainippon Pharma Co., Ltd. - 2016-09-09](https://www.globalkeysolutions.net/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/151acf38-3655-484e-940e-d2c279207079) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 9, 2016
- [FDA Inspection 853865 - Sumitomo Dainippon Pharma Co., Ltd. - 2013-11-01](https://www.globalkeysolutions.net/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/08db7714-ba67-434c-a54b-e91f0f392dfd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 1, 2013
- [FDA Inspection 770009 - Sumitomo Dainippon Pharma Co., Ltd. - 2012-02-23](https://www.globalkeysolutions.net/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/2730b192-bf1e-46a8-9b09-b4b5ce9b10dd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 23, 2012
- [FDA Inspection 770009 - Sumitomo Dainippon Pharma Co., Ltd. - 2012-02-23](https://www.globalkeysolutions.net/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/262a3d80-b465-4788-b2e0-b54347eb7b48) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 23, 2012

## Related Companies

- [Cipla, Ltd.](https://www.globalkeysolutions.net/companies/cipla-ltd/f726d9c8-4fe7-456e-848c-f9ef86f00e4f)
- [Gland Pharma Limited](https://www.globalkeysolutions.net/companies/gland-pharma-limited/dd730d79-1c97-4fb0-b717-c0ebd71a5b3f)
- [Biological E. Limited](https://www.globalkeysolutions.net/companies/biological-e-limited/a02640a2-3dc0-448e-9a4f-df7e189939e4)
- [Serum Institute of India Pvt. Ltd.](https://www.globalkeysolutions.net/companies/serum-institute-of-india-pvt-ltd/a1288932-02ec-49e6-942a-e8d90c93b890)
- [Sinopep-Allsino Biopharmaceutical Co., Ltd.](https://www.globalkeysolutions.net/companies/sinopep-allsino-biopharmaceutical-co-ltd/f45b83cf-0416-4308-92bf-f7f3212ca356)
- [Boehringer Ingelheim Fremont, Inc.](https://www.globalkeysolutions.net/companies/boehringer-ingelheim-fremont-inc/3d7d0ca7-27cd-4223-8ade-7193417c9861)
- [Bavarian Nordic Berna GmbH](https://www.globalkeysolutions.net/companies/bavarian-nordic-berna-gmbh/c041bdf1-c3d5-46c3-a216-02ad314f45e0)
- [Juno Therapeutics, Inc.](https://www.globalkeysolutions.net/companies/juno-therapeutics-inc/d564709e-29d0-4aaf-9d68-efbf3cd67a35)
- [BioMarin International Limited](https://www.globalkeysolutions.net/companies/biomarin-international-limited/dbd5911b-3dec-4a03-a980-1e45a5f973a4)
- [Lonza Houston, Inc](https://www.globalkeysolutions.net/companies/lonza-houston-inc/c3ae4db9-9aba-4b65-9e2b-06e1632112a6)

## Related Officers

- [Jogy George](https://www.globalkeysolutions.net/people/jogy-george/00ef0915-66d2-4b34-9b74-d1e08caf2db3)
- [ Drug Investigator](https://www.globalkeysolutions.net/people/tekalign-wondimu/3b80e5c8-4062-4e1d-8ddd-b1afa2616dec)